Chester County News and Community Website
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) will present Phase 3 data this month examining whether its experimental hypertension drug lorundrostat reduced both blood pressure and albuminuria in patients …
Mineralys Extends Lorundrostat Focus to Kidney Disease Read More RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) will present five studies of lorundrostat at the American Heart Association’s Hypertension Scientific Sessions this week, extending its clinical work beyond uncontrolled …
Mineralys Expands Lorundrostat Data Across Hypertension Uses Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported a new analysis showing patients treated with YCANTH cleared molluscum contagiosum at about four times the rate of those receiving …
Verrica Analysis Shows Faster Clearance With YCANTH Read More
WAYNE, PA — TekniPlex Healthcare is expanding its pharmaceutical materials portfolio around PFAS-free packaging, cleaner dispensing components and flexible drug reservoirs as drugmakers face pressure to protect increasingly sensitive therapies …
TekniPlex Targets Pharma Shift Away From Legacy Materials Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) Chief Executive Officer Shankar Musunuri will discuss regulatory approval and commercialization of cell and gene therapies at an industry conference Oct. 6 in …
Ocugen CEO to Address Gene Therapy Commercialization Read More
WEST CHESTER, PA — Mole Street and HubSpot will use new survey data from 270 U.S. financial services leaders to argue that fragmented data and weak technology integration are constraining …
West Chester’s Mole Street Flags Data Silos as Growth Barrier Read More
LANGHORNE, PA — Perspecta will target third-party administrators and self-insured employers at the 2026 SIIA National Conference in Phoenix next month, positioning its provider-data technology as a way to reduce …
Perspecta Targets Self-Insured Plans With Provider Data Tools Read More
PHILADELPHIA, PA — IntegriChain will use three pharmaceutical industry conferences this fall to address changes in government drug pricing, 340B, gross-to-net forecasting and distribution, as manufacturers contend with regulatory and …
IntegriChain Targets Drug Pricing Shifts at Fall Conferences Read More RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will participate in the Stifel 2026 Virtual Cardiometabolic Forum on Sept. 30, giving investors an opportunity to hear from management as the …
Mineralys Sets Investor Forum Appearance as Lorundrostat Advances Read More RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will present new long-term efficacy and safety data for lorundrostat in November, providing an additional clinical readout as the company advances the …
Mineralys to Present Long-Term Lorundrostat Data in November Read More